Medicare plans are replacing brand-name buprenorphine-naloxone film with its generic equivalents, resulting in a decrease in out-of-pocket cost faced by enrollees with opioid use disorder.
Hao Zhang, PhD
Advertisement
Articles by Hao Zhang, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
US Employer Health Care Costs Projected to Rise 9.5% in 2027
2
FDA Clears First Single-Biomarker Blood Test for Alzheimer
3
Lung Cancer Task Force Maps Research Roadmap to Close Survival Gap
4
New York Experts Push for Coordinated Obesity Care Teams
5